Weekly NCLEX Practice Question

Introduction

• Presented by Sarah, RN from RN.com
• Focus: Weekly NCLEX practice question
• Encouragement to check out other questions in the series

Practice Question

• Scenario:
  • Patient's blood glucose: 215 mg/dL
  • Administer 4 units of Insulin Lispro (Humalog) subcutaneously at 11:30
  • Question: At what time is the patient most at risk for hypoglycemia?
  • Options: A) 11:45 B) 12:30 C) 14:30 D) 16:30

Analyzing the Scenario

• Blood Sugar Levels:

  • Normal pre-meal range: 70-130 mg/dL
  • Patient's blood sugar is high at 215 mg/dL
  • Insulin is needed before meals to prevent further increase

• Insulin Type:

  • Lispro (Humalog) is a rapid-acting insulin

Insulin Categories

• Types of Insulin:

  • Rapid: Lispro (Humalog), Aspart (Novolog), Glulisine (Apidra)
  • Short: Regular insulins (Humulin R, Novolin R)
  • Intermediate: NPH (cloudy insulins like Humulin N, Novolin N)
  • Long: Lantus (Glargine), Levemir (Detemir)

• Focus on Rapid-Acting Insulin:

  • Key terms: Onset, Peak, Duration
  • Mnemonic: "15 minutes feels like an hour during 3 rapid responses"
    • Onset: 15 minutes
    • Peak: 1 hour
    • Duration: 3 hours

Risk of Hypoglycemia

• Hypoglycemia Risk:

  • Occurs when insulin is at its peak
  • Peak for Lispro is 1 hour after administration

• Question Analysis:

  • Insulin was given at 11:30
  • Peak time (hypoglycemia risk): 12:30
  • Correct answer: B) 12:30

Conclusion

• Emphasize organization and understanding onset, peak, and duration
• Invite to explore more NCLEX questions and lectures

This summary provides an understanding of how to assess the timing for hypoglycemia risk with rapid-acting insulins, specifically Lispro, and how to apply this to NCLEX questions.